H. Res. 1485 
In the House of Representatives, U. S., 
September 28, 2010. 
Whereas countless families in the United States live with 
prostate cancer; 
Whereas 1 in 6 men in the United States will be diagnosed 
with prostate cancer in his lifetime; 
Whereas prostate cancer is the most commonly diagnosed 
non-skin cancer and the second most common cause of 
cancer-related deaths among men in the United States; 
Whereas in 2010, 217,730 men in the United States will be 
diagnosed with prostate cancer and 32,050 men in the 
United States will die of prostate cancer; 
Whereas 30 percent of new diagnoses of prostate cancer 
occur in men under the age of 65; 
Whereas a man in the United States turns 50 years old ap-
proximately every 14 seconds, increasing his odds of de-
veloping cancer, including prostate cancer; 
Whereas African-American males suffer a prostate cancer in-
cidence rate up to 65 percent higher than White males 
and double the prostate cancer mortality rates of White 
males; 
Whereas obesity is a significant predictor of the severity of 
prostate cancer and the probability that the disease will
•HRES 1485 EH 
lead to death, and high cholesterol levels are strongly as-
sociated with advanced prostate cancer; 
Whereas if a man in the United States has 1 family member 
diagnosed with prostate cancer, he has a 1 in 3 chance 
of being diagnosed with prostate cancer, if he has 2 fam-
ily members with such diagnoses, he has an 83 percent 
risk, and if he has 3 family members with such diag-
noses, he then has a 97 percent risk of prostate cancer; 
Whereas screening by both a digital rectal examination and 
a prostate-specific antigen blood test can detect the dis-
ease in its early stages, increasing the chances of sur-
viving more than 5 years to nearly 100 percent, while 
only 33 percent of men survive more than 5 years if diag-
nosed during the late stages of the disease; 
Whereas there are no noticeable symptoms of prostate cancer 
while it is still in the early stages, making screening crit-
ical; 
Whereas ongoing research promises further improvements in 
prostate cancer prevention, early detection, and treat-
ments; 
Whereas educating people in the United States, including 
health care providers, about prostate cancer and early de-
tection strategies is crucial to saving the lives of men and 
preserving and protecting families; and 
Whereas September 2010 would be an appropriate month to 
designate as ‘‘National Prostate Cancer Awareness 
Month’’: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of ‘‘National Prostate 
Cancer Awareness Month’’;
•HRES 1485 EH 
(2) declares that steps should be taken— 
(A) to raise awareness about the importance of 
screening methods for, and treatment of, prostate 
cancer; 
(B) to support research so that the screening 
and treatment of prostate cancer may be improved, 
and so that the causes of, and a cure for, prostate 
cancer may be discovered; and 
(C) to continue to consider ways for improving 
access to, and the quality of, health care services 
for detecting and treating prostate cancer; and 
(3) calls on the people of the United States, inter-
ested groups, and affected persons— 
(A) to promote awareness of prostate cancer; 
(B) to take an active role in the fight to end 
the devastating effects of prostate cancer on indi-
viduals, their families, and the economy; and 
(C) to observe National Prostate Cancer 
Awareness Month with appropriate ceremonies and 
activities. 
Attest: 
Clerk.